Evidence-based · Educational only
36+ Peptides indexed
Free research library
Free newsletter — subscribe below
★ = FDA-approved medical indication
Not medical advice — always consult a clinician
Evidence-based · Educational only
36+ Peptides indexed
Free research library
Free newsletter — subscribe below
★ = FDA-approved medical indication
Not medical advice — always consult a clinician
All peptides

Follistatin-344

Also known as: FST-344
Research / Investigational

Follistatin-344 is a 344-amino-acid isoform of the endogenous myostatin/activin inhibitor follistatin, investigated for muscle growth and muscular dystrophies.

Buy Follistatin-344 on American Peptides

Affiliate link — we may earn a commission at no extra cost to you.

Overview

Follistatin-344 is a 344-amino-acid isoform of the endogenous myostatin/activin inhibitor follistatin, investigated for muscle growth and muscular dystrophies.

FDA Approval Status

Not approved by the FDA. Investigational or intended for research purposes only.

Mechanism of Action

Binds and neutralizes myostatin and activin, disinhibiting muscle protein synthesis.

Current Research

Gene-therapy trials for Duchenne and Becker muscular dystrophy; peptide/protein form remains investigational.
Research strength: Preliminary

Potential Medical Uses

  • Investigational only

Potential Benefits

  • Increased muscle mass in preclinical models

Known Side Effects

  • Injection-site reactions
  • Long-term human safety unknown

Contraindications

  • Pregnancy
  • Active malignancy

Drug Interactions

  • Anabolic agents (theoretical)

Administration Methods

  • Subcutaneous or intramuscular injection (research)

Half-life

Hours to days depending on isoform

Reconstitution

Bacteriostatic water.

Storage & Handling

Refrigerated reconstituted; frozen long-term.

References & Sources

Frequently Asked Questions

Information on this page is educational and general in nature. It is not medical advice. Consult a qualified healthcare professional before making any medical decisions.